Alex Therapeutics Partners With Navamedic On Parkinson`s Disease App
12 Sep 2024 //
PR NEWSWIRE
Navamedic Q2 And H1 2024: Stable Growth Supported By New Licensing Agreement
16 Aug 2024 //
PR NEWSWIRE
Navamedic & Orion Corporation sign License & Supply Agreement for Flexilev
24 Jun 2024 //
PRESS RELEASE
Navamedic Renews Norwegian Hospital Antibiotics Contract
16 May 2024 //
PR NEWSWIRE
Navamedic ASA: Broad launch for Eroxon® in Sweden today
06 May 2024 //
PR NEWSWIRE